Critical Sorting Steps and Pathways in the Trafficking of Cardiac Sarcoplasmic Reticulum Proteins

心脏肌浆网蛋白运输的关键分选步骤和途径

• 批准号: 10719667
• 负责人: Zhenhui Chen
• 金额: $ 66.51万
• 依托单位: INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-06-15 至 2027-03-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10719667
• 关键词: Adrenergic Agents; Adult; Anabolism; Animal Model; Binding; Biochemical; Cardiac; Cardiac Myocytes; Carrier Proteins; Cell membrane; Cells; Chronic; Communication; Complex; Cytoplasm; Data; Dedications; Disease; Distal; Endoplasmic Reticulum; Failure; Functional disorder; Golgi Apparatus; Growth; Heart; Heart Diseases; Heart Hypertrophy; Heart failure; Hypertrophy; Immunologics; Immunology procedure; Intercalated disc; Knowledge; Lead; Location; Membrane; Membrane Proteins; Messenger RNA; Microtubules; Molecular; Morphology; Motor; Muscle Cells; Nuclear; Nuclear Envelope; Nuclear Pore; Organ failure; Pathway interactions; Peptide Signal Sequences; Physiological; Preparation; Process; Protein Biosynthesis; Protein Sortings; Proteins; Proteome; Proteomics; Pump; Radial; Regulation; Ribosomes; Rough endoplasmic reticulum; Ryanodine Receptor Calcium Release Channel; SERCA2a; Sarcolemma; Sarcomeres; Sarcoplasmic Reticulum; Site; Sorting; Subcellular structure; Symptoms; System; Tertiary Protein Structure; Testing; Therapeutic; Therapeutic Intervention; Translating; Translations; Transmembrane Domain; Tubular formation; design; guided inquiry; mRNA Translation; new therapeutic target; novel; novel therapeutics; phospholamban; phospholemman; protein distribution; protein transport; response; rough endoplasmic reticulum cisterna; sex; targeted treatment; therapeutic target; therapeutically effective; trafficking; uptake

Cardiac hypertrophy can lead to heart failure, with few treatment options. Hypertrophic growth inevitably requires mechanisms of protein distribution, as studies show the involvement of both increased mRNA translation and mRNA trafficking along microtubules. Yet, how the distribution of membrane proteins occurs and responds to hypertrophic growth is unknown. While sarcoplasmic reticulum (SR) Ca handling is key to hypertrophy, we do not know how trafficking of SR proteins occurs using cardiomyocyte specific mechanisms, nor its regulation and response to hypertrophy, which precludes discovery of key targets for therapeutics. To probe this mechanism and identify sites of regulation, we have focused on a common portion of the biosynthetic membrane pathway where the rough endoplasmic reticulum (ER) organizes and sorts proteins for transit into SR tubules. Using a species-specific expression and immunological analysis to study the early steps of SR protein trafficking in adult cardiomyocytes, we show that newly synthesized proteins first accumulate into organized perinuclear ER puncta aligned with z-lines, and then transit to transverse SR z-tubules that aligned with T-tubules. Such morphology is observed for all newly made proteins examined, except for phospholamban, suggesting commonality of these protein sorting sites in ER. Afterward, motors can power transport of proteins both radially and axially via microtubules to their steady state distributions. These data lead to our hypotheses that newly synthesized SR proteins are sorted in a specific set of perinuclear ER subdomains, which are organized by the alignment with z-lines and in proximity to nuclear pores and translocons, contain critical ER trafficking proteins, and allow newly made SR proteins to develop their initial functional interactions for transit to SR. Such cellular sorting and trafficking steps adapt to the physiological demands, but maladapt to hypertrophic heart failure, which are likely amenable to develop new therapeutics regulating membrane protein trafficking. To dissect biochemical features of these sorting sites and trafficking steps, we have developed key experimental systems to determine progressive protein distribution 12-48 h after translation of three small single transmembrane domain proteins that are destined to different subcellular locations. Included is phospholamban (in the nuclear envelope and in longitudinal SR for Ca uptake), junctin (in junctional SR for Ca release), and phospholemman (in sarcolemma and intercalated discs to regulate the Na, K-pump). Aim 1 will determine: if a single perinuclear ER subdomain can effectively accumulate and co-localize newly made SR proteins (junctin and phospholamban), but separate phospholemman, for their diverse and distinct steady state distributions; if sites are aligned with nuclear pores, translocons; and if known ER trafficking proteins, newly identified in our SERCA-activated SR proteome, will modulate these trafficking steps. Aim 2 will determine whether a hypertrophic response modulates the accumulations of protein into any of the ER sorting sites, their common biosynthesis pathways, or the novel sets of cardiac ER trafficking proteins, in animal models of hypertrophy.

心脏肥厚可导致心力衰竭，治疗选择很少。肥厚生长不可避免